PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 123 filers reported holding PROVENTION BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,352,034 | +113.7% | 56,101 | -6.3% | 0.00% | – |
| Q4 2022 | $632,594 | +2650.4% | 59,848 | +1059.8% | 0.00% | – |
| Q3 2022 | $23,000 | +4.5% | 5,160 | -6.6% | 0.00% | – |
| Q2 2022 | $22,000 | -69.0% | 5,527 | -42.7% | 0.00% | – |
| Q1 2022 | $71,000 | -58.2% | 9,644 | -68.2% | 0.00% | – |
| Q4 2021 | $170,000 | +132.9% | 30,300 | +165.9% | 0.00% | – |
| Q3 2021 | $73,000 | -65.6% | 11,396 | -54.6% | 0.00% | – |
| Q2 2021 | $212,000 | -24.6% | 25,083 | -6.5% | 0.00% | – |
| Q1 2021 | $281,000 | -68.7% | 26,822 | -49.4% | 0.00% | – |
| Q4 2020 | $898,000 | +104.6% | 53,008 | +54.9% | 0.00% | – |
| Q3 2020 | $439,000 | -32.7% | 34,217 | -26.0% | 0.00% | – |
| Q2 2020 | $652,000 | +78.1% | 46,258 | +16.3% | 0.00% | – |
| Q1 2020 | $366,000 | -53.6% | 39,772 | -24.9% | 0.00% | – |
| Q4 2019 | $788,000 | +622.9% | 52,957 | +231.0% | 0.00% | – |
| Q3 2019 | $109,000 | -43.8% | 16,000 | 0.0% | 0.00% | – |
| Q2 2019 | $194,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |